Discontinued — last reported Q3 '23
Intangible assets — net
ResMed Intangible assets — net decreased by 1.2% to $425.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from $430.11M to $425.19M. Over 4 years (FY 2021 to FY 2025), Intangible assets — net shows an upward trend with a 4.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher values indicate significant investment in proprietary technology or market access, though they require monitoring for potential impairment.
Detailed definition
This represents the net value of identifiable intangible assets with a limited useful life, such as patents, licenses, o...
Peer comparison
Common in technology, pharmaceutical, and defense firms that acquire or develop proprietary intellectual property.
non_current_assets_finite_lived_intangible_assets_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $392.58M | $375.40M | $372.01M | $355.98M | $345.94M | $338.15M | $586.86M | $569.68M | $552.34M | $563.28M | $528.18M | $501.02M | $485.90M | $478.61M | $438.00M | $430.11M | $464.86M | $447.07M | $430.24M | $425.19M |
| QoQ Change | — | -4.4% | -0.9% | -4.3% | -2.8% | -2.3% | +73.5% | -2.9% | -3.0% | +2.0% | -6.2% | -5.1% | -3.0% | -1.5% | -8.5% | -1.8% | +8.1% | -3.8% | -3.8% | -1.2% |
| YoY Change | — | — | — | — | -11.9% | -9.9% | +57.8% | +60.0% | +59.7% | +66.6% | -10.0% | -12.1% | -12.0% | -15.0% | -17.1% | -14.2% | -4.3% | -6.6% | -1.8% | -1.1% |
Intangible assets — net at Other Companies
Frequently Asked Questions
- What is ResMed's intangible assets — net?
- ResMed (RMD) reported intangible assets — net of $425.19M in Q1 2026.
- How has ResMed's intangible assets — net changed year-over-year?
- ResMed's intangible assets — net decreased by 1.1% year-over-year, from $430.11M to $425.19M.
- What is the long-term trend for ResMed's intangible assets — net?
- Over 4 years (2021 to 2025), ResMed's intangible assets — net has grown at a 4.3% compound annual growth rate (CAGR), from $392.58M to $464.86M.
- What does intangible assets — net mean?
- The value of non-physical assets with a limited lifespan, like patents or licenses.